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SUMMARY 
Placozoans, together with sponges, are the only animals devoid of a nervous system 
and muscles, yet both respond to sensory stimulation in a coordinated manner. How 
behavioural control in these free-living animals is achieved in the absence of neurons 
and, more fundamentally, how the first neurons evolved from more primitive cells for 
communication during the rise of animals is not yet understood [1-5]. The placozoan 
Trichoplax adhaerens is a millimeter-wide, flat, free-living marine animal composed 
of six morphologically identified cell types distributed across a simple bodyplan [6-
9]: a thin upper epithelium and a columnar lower epithelium interspersed with a loose 
layer of fiber cells in between. Its genome contains genes encoding several 
neuropeptide-precursor-like proteins and orthologs of proteins involved in 
neurosecretion in animals with a nervous system [10-12]. Here we investigate 
peptidergic signalling in Trichoplax adhaerens. We found specific expression of 
several neuropeptide-like molecules in non-overlapping cell populations distributed 
over the three cell layers, revealing an unsuspected cell-type diversity of Trichoplax 
adhaerens. Using live imaging, we discovered that treatments with 11 different 
peptides elicited striking and consistent effects on the animals’ shape, patterns of 
movement and velocity that we categorized under three main types: (i) crinkling, (ii) 
turning, and (iii) flattening and churning. Together, the data demonstrate a crucial role 
for peptidergic signalling in nerveless placozoans and suggest that peptidergic volume 
signalling may have predated synaptic signalling in the evolution of nervous systems.  
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RESULTS AND DISCUSSION 
 
Trichoplax adhaerens comprises multiple populations of peptide-secreting cells 
Peptidergic communication is widely used throughout most of the animal kingdom. It 
may even predominate neural communication in phyla such as cnidarians and 
ctenophores [11,13]. The importance of secreted peptides in placozoan physiology 
and behaviours is not known. The genome of T. adhaerens encodes for determinants 
of both classical and peptidergic (neuro-)transmission [10-12]. Among the putative 
peptide signalling-molecules predicted from the genome [11,12], we selected 
candidates with good antigenic profiles to generate antibodies. We chose five peptides 
bearing an amidation site (SIFGamide, SITFamide, YYamide, RWamide and 
FFNPamide) as well as one of the four predicted insulin-like peptides, TrIns3. 
Immunostainings with the affinity purified antibodies in whole-mount T. adhaerens 
uncovered six populations of cells with distinct distribution patterns (Figure 1A-C). 
Upon co-labelling experiments [14], these peptides were never found to be co-
expressed, as illustrated for SIFGamide, SITFamide and FFNPamide (Figure 1B) and 
SITFamide, FFNPamide and TrIns3 (Figure S1). Instead, it appears that each of the 
six populations of peptide-secreting cells spreads concentrically, delineating distinct 
territories (Figure 1C). Starting from the outside of the animal towards its inside, 
SIFGamide immunoreactive cells are found at the very edge and the outer rim of the 
upper epithelium. SITFamide cells distribute further inwards in the upper epithelium, 
in an equally broad annular area. Together, the description of these populations 
validates and refines the suggested rim-vs-centre cell composition of T. adhaerens 
[7,8]. Intriguingly, TrIns3-labelled cells are located in the lower epithelium along a 
thin ring across the boundaries of the SIFGamide and SITFamide territories. A few, 
small TrIns3-reactive cells are at times also found at the edge.  
 Earlier studies using antibodies against RFamide [15] or FMRFamide [8] have 
identified putative peptidergic cells at the rim. Ciliated, endocrine-like cells with 
neurosecretory features (e.g. expressing SNARE proteins) have also previously been 
described at the rim and named gland cells [6-8]. Since no FMRFamide peptide 
precursor could be identified in the T. adhaerens genome, we asked whether labelling 
with anti-FMRFamide antibodies could derive from cross-reactivity with (some of) 
the populations of newly-identified cells. Upon co-immunolabelling with commercial 
anti-FMRFamide antibodies, we observed indeed that SITFamide-expressing cells 
and, more faintly, TrIns3-expressing cells are also labelled by these antibodies. Anti-
FMRF antibodies also label cells near the rim of the animal that are not labelled by 
any of the tested antibodies. These observations suggest that anti-FMRFamide 
antibodies detect SITFamide and maybe other peptides (Figure S1).  
The remaining three populations of peptide-secreting cells, expressing RWamide, 
FFNPamide and YYamide distributed away from the rim in more central parts of the 
organism. Labelling for RWamide is confined to the inside of the organism and does 
not reach to the surface. The fluorescent peptidergic granules distribute tightly around 
a rather small nucleus located deep in the middle of the organism. Since they are not 
observed in correlation with autofluorescent particles nor with large nuclei or cell-
bodies, we suggest that RWamide-secreting cells do not correspond to the large and 
complex fiber cells, landmark of the intermediate, non-epithelial layer [7,8] but to 
another, as yet unidentified cell type. RWamide cells spread within a very large ring, 
sometimes even to the centre of the organism (Figure 1C). Finally, cells expressing 
FFNPamide and YYamide mix and mingle in the centre part of the lower epithelium. 
FFNPamide cells are thin and tall and more abundant than YYamide cells, while the 
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latter appear larger and filled with numerous labelled granules. In this region, 
cylindrical epithelial cells, lipophil cells and another population of putative endocrine 
cells (labelled with SNAREs but not FMRFamide antibodies) have been reported 
[7,8]. Whether FFNPamide and/or YYamide-cells may correspond to SNARE-
expressing cells cannot be addressed currently since available antibodies did not allow 
for double-labelling. T. adhaerens' genome encodes several isoforms of secretory 
SNARE proteins [16], and the specificity of antibodies used so far is unclear. It is 
likely that different populations of secretory cells with different sets of secretory 
SNARE protein isoforms exist in T. adhaerens. 
 In summary, we uncovered an unexpected diversity of peptidergic cells with 
unique concentric distribution patterns (Figure 1C) in this morphologically simple 
animal. This suggests that secreted peptides have unique signalling functions 
potentially regulating many aspects of T. adhaerens physiology. 
 
Neuropeptide-like molecules elicit strong stereotypical behaviours in Trichoplax 
adhaerens 
Placozoans move slowly across surfaces using a densely ciliated lower epithelium [9]. 
They produce stereotypical behaviours as they flip, fold, flatten, rotate and constantly 
change their shape [17-20] in a highly coordinated manner. The animals also change 
their speed as a function of light intensity [19] or presence of food [8,18,19,21-23]. 
Their extra-organismal feeding behaviour is particularly complex [18,21]. How T. 
adhaerens coordinates such movements is only beginning to emerge. 
 To test the effects of peptides on T. adhaerens' behaviour, we recorded over 
50 min the motor behaviour of several individuals. At 15 min,  we applied each one of 
eleven synthetic peptides predicted from T. adhaerens neuropeptide-precursor-like 
proteins. We tested the peptides ELPE, FFNPamide, LF, LFNE, MFPF, PWN, 
RWamide, SIFGamide, SITFamide, WPPF and YYamide (Tables S1 & S2; note that 
ELPE and MFPF have not been reported so far). We used peptides at varying 
concentrations across trials (200 nM to 50 M; Table S1; in-depth analysis was 
performed for 20 M peptide). We observed strong effects on behaviour following 
peptide treatment, indicating that the peptides reached their targets, as expected from 
the anatomy of the organism [22]. Several parameters including the area and shape 
(roundness) of the organisms, as well as locomotion speed and path trajectories were 
scored. The timing and extent of individual responses varied considerably, making it 
impractical to reflect the effects in averaged datasets. Hence we show averaged and 
individual responses as appropriate depending on the nature of the effect of each 
peptide. 
 In the majority of cases, the peptides elicited strong and characteristic changes 
in movement. We categorized these changes under three general types: (i) crinkling, 
(ii) rounding up and rotating, and (iii) flattening and churning. 
 Upon application of PWN, T. adhaerens immediately crinkled, as reflected by 
a sharp decrease in the area of the animals. The effect lasted for approximately 10 
minutes, after which the animals recovered their normal shape (Figure 2A, C-D; 
Movie S1). Application of SIFGamide induced even stronger crinkling that led to an 
approximate 50 % decrease in the area, an effect from which the animals only started 
to recover by the end of the recording (Figure 2E, G-H). In addition, SIFGamide-
treated animals often detached from the substrate (Movie S2). Detachment was briefly 
reported elsewhere [24]. T. adhaerens adopts a similar shape in response to UV light 
[25] or when flushed with a strong water stream. 
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 The application of LF and LFNE peptides triggered a different type of 
morphological and behavioural change. Both peptides induced the animals to rotate 
for several minutes around a fixed axis (arrows in Figure 3E) or to move in circular 
trajectories (Figure 3B, F; Movies S3 & S4). They transiently flattened, while keeping 
their round shape, to reach up to 240 % (LF; Figure 3D) or 130 % (LFNE; Figure 3H) 
of their average area. Upon LF application, animals rapidly adopted a smooth round 
shape (Figure 3A) and rotated around themselves and in the dish. While the animals 
recovered, their edges were seen undulating at times. Upon LFNE application, the 
majority of animals rounded up, often adopting a spiral shape (Figure 3E) and turned 
around themselves (Figure 3F). A few individuals elongated or undulated at the 
edges. 
 Another group of peptides, comprising FFNPamide, ELPE, MFPF and WPPF, 
induced actions reminiscent of feeding behaviour, without entirely recapitulating the 
feeding sequence (Movies S5-8). When feeding, T. adhaerens stops moving before a 
large fringe of its periphery stretches and flattens down, adhering to the bottom. 
Meanwhile, its central part undergoes coordinated rhythmic movements including 
stretching, contracting and rotating components ("churning" [18,21]). The animal then 
loosens itself from the bottom and resumes crawling. All four peptides increased the 
number of flattening events (Figure 4C, G, K, O), as shown by an increase in average 
area (Figure S2). Most often, flattening and pausing events occurred concomitantly 
(Figure 4B vs. D, J vs. L, N vs. P), while they were occasionally slightly shifted 
(Figure 4F vs. H). Flattening induced by FFNP was extreme, as the centre part of the 
organism appeared extremely pale. This suggests that the animal is able to thin out to 
an extent that has not been reported before - up to 5 times its "default" size. ELPE, 
MFPF and WPPF induced the animals to adhere more tightly to the dish at their rim 
(which hence appears paler (Figure 4E, I, M)), to flatten down and to churn with 
slightly different movements. In the presence of MFPF, animals churn slower or 
faster than untreated animals, and for extended periods of time. FFNPamide addition 
also triggered moderate churning movements. Interestingly, the numerous 
FFNPamide-immunoreactive cells embedded in the lower epithelium (Figure 1) are 
found in the same area as the digestive enzyme-releasing lipophil cells [8,21], hence 
are well positioned to fulfil a role in modulating feeding behaviour [4,26]. Altogether, 
these behaviours could be subprograms of the motor alterations associated with the 
food uptake process. Whether the peptides involved are acting independently, 
sequentially or in synergy requires further investigation. 
 Finally, a few peptides induced only subtle alterations in T. adhaerens 
behaviour (Figure S3; Movies S9-11). Neither SITFamide, YY, nor different 
RWamide peptides affected the flattening rate of the animals. SITFamide induced an 
effect which was difficult to quantify. The speed of the animals was significantly 
lower during the 30 minutes monitored after SITFamide application. Some animals 
slowed down (Figure S3D) without stopping (Figure S3A, B). In one case, an animal 
stopped but did not flatten (2_102, Figure S3). Application of YYamide resulted in a 
small but significant increase in the speed of or the distance travelled by the animals 
during the later phase of the recordings (Figure S2G). In one case, an animal 
increased its area without slowing down (1_128, Figure S3). Finally, the effects of 
RWamides were tested in a pilot series of experiments using the three slightly 
different peptides RWamide1, RWamide2, RWamide3 and their respective forms 
bearing a N-terminal pyroGlutamine modification pGluRWamide1, pGluRWamide2 
and pGluRWamide3. No drastic effect was observed over the 30 minutes of 
recordings. Hence, pRWamide2 was arbitrarily selected for further trials. No change 
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in area, trajectory, speed or distance travelled was noted. Application of the vehicle 
alone did not alter the animals' behaviour (Figure S4; Movies S12; S13). 
 Overall, our data show that most predicted peptides are able to strongly alter 
T. adhaerens behaviour. This suggests that peptidergic signalling pathways that can 
affect the animals’ contractility and movements are in place. Moreover, we describe a 
previously undocumented capacity of extreme physical alterations of T. adhaerens, 
from extreme flattening to crinkling and from churning to rotating. Our results 
suggest that motor behaviours in T. adhaerens likely result from the coordinated 
interplay of several cellular arrays that are under the strong influence of peptidergic 
signals. 
 An earlier study reports that gland cells secrete an endomorphin-like peptide 
(TaELP), which arrests ciliary beating, inducing feeding-like pauses [24] (Figure S5). 
Interestingly, we observed that the application of the endomorphin-like peptide also 
induced flattening but no churning (Table S1). At lower concentrations, crinkling was 
observed, whereas high concentrations caused the animal to rotate. Changes in 
movement may rely in part on changes in ciliary beating. Flattening may be generated 
by fast contractions of epithelial cells [20] or by contractions of the large, 
actin/microtubule-rich fiber cells. These are located in between the two epithelial 
layers [26,27] and are connected to each other and contact all cell types [8]. 
 Peptide signalling molecules and their respective receptors appeared early in 
metazoan evolution and have been described in all animals with a nervous system 
including ctenophores [13,28] and cnidarians. Our study suggests that peptide 
signalling molecules play an important role in cell-cell communication in T. 
adhaerens as well. Of note, the genome of T. adhaerens encodes a rich repertoire of 
G-protein coupled receptors [10,29], at least some of which likely act as receptors for 
the peptides characterised in this study [11]. The peptide signalling systems in T. 
adhaerens are less complex than those of eumetazoans and might thus represent a 
more ancestral stage [11]. It will be interesting to explore the occurrence and actions 
of peptide signalling molecules in other placozoans [30,31]. Since the T. adhaerens 
genome also contains all determinants of transmission via classical neurotransmitters 
[10], it will be essential to scrutinize whether the animal combines elements of 
peptide and classical transmission. The peptide-containing cells described herein 
might represent specialized, non-neuronal secretory cells or neuroendocrine-
like/neuron-like cells. These cell may be able to co-release both types of transmitters 
as is found in neurons and endocrine cells in animals with nervous systems [32].  
 Altogether, our data demonstrate that cell-type diversity in placozoans is 
higher than previously inferred [7,8] and that several specialized cell types, regarded 
as the "basal building blocks of multicellular organisms" [33], have already emerged 
in this phylum. Indeed, a recent single-cell transcriptome study also revealed the 
presence of several hitherto unexplored lower-frequency cell types expressing unique 
signalling peptides [34] (Figure S6). In T. adhaerens, several populations of 
topographically organized peptide-secreting cells can strongly modulate the animals' 
movements. Our results suggest that peptidergic signalling is an important mode of 
communication for placozoans, as is the case for cnidarians and bilaterians [11,35-
39]. 
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FIGURE LEGENDS 
 
Figure 1. Distribution of peptide-secreting cells in Trichoplax adhaerens. 
(A) Cells expressing SIFGamide, SITFamide, TrIns3, RWamide, FFNPamide and 
YYamide are spatially organized. Maximal intensity projection images illustrate 
populations of labelled cells (green) for the indicated peptides upon whole-mount 
immunostaining of T. adhaerens individuals. Images show the cumulative positions 
of labelled cells from above (left panel) and from the side (in a 10 m slice; middle 
panel). Representative cells of each population are shown at high magnification in 
their long axis (horizontal for SIFGamide, SITFamide and RWamide cells, vertical 
for TrIns3, FFNPamide and YYamide; right panel). The size and distribution of 
labelled granules widely vary across cell populations. Hoechst-stained nuclei (blue) 
and auto-fluorescent particles (red) serve as landmarks to locate the upper and lower 
epithelial layers. (B) Populations of peptidergic cells do not overlap. A maximal 
intensity projection confocal image illustrates the partitioned distribution of 
SIFGamide (green), SITFamide (blue) and FFNPamide (red)-immunoreactive cells in 
T. adhaerens. Of note, DAPI staining was recorded in a fourth channel (not shown), 
and the unspecific labelling common to all four channels, which corresponds to 
numerous round-shaped auto-fluorescent "concrement vacuoles", was subtracted from 
the image for clarity. (C) Schematic representation of the respective positions of 
peptidergic-immunoreactive cell populations in T. adhaerens, on top and side views, 
similar to the planes in A. Of note, SITFamide sera also faintly labelled the 
mitochondrial clusters of fiber cells (not shown).  
*, upper edge of the animal; le, lower epithelium; ue, upper epithelium. Scale bars: in 
A, 10 m for the left and middle panels, 4 m for the right panel; in B, 10 m. See 
also Figures S1 and S6 and Table S2. 
 
 
Figure 2. PWN and SIFGamide elicit partial detachment and folding of 
Trichoplax adhaerens. 
Representative images (A, E), trajectory (B, F) and surface area over time (C, G) of  
T. adhaerens individuals upon a single batch application of 20 M PWN (A-D) or 
SIFGamide (E-H). (D, H) Average surface area variations (Mean+StDev) upon 20 
M PWN (n=22 animals in 5 trials) or SIFGamide (n=23 animals in 6 trials). 
Travelling paths (in grey/black: before/after application) do not show major alteration 
in trajectories, illustrating that T. adhaerens remain attached at the bottom of the dish. 
Scale bars: 250 m in A, 200 m in B and F, 170 m in E. See also Figure S4 and 
Tables S1 and S2. 
 
 
Figure 3. LF and LFNE induce rotation and extreme flattening of Trichoplax 
adhaerens. 
Representative images (A, E), trajectory (B, F) and surface area over time (C, G) of  
T. adhaerens individuals upon a single batch application of 20 M LF (A-D) or LFNE 
(E-H). (D, H) Average surface area variations (Mean + StDev) upon 20 M LF (n=12 
animals in 3 trials) or LFNE (n=22 animals in 5 trials). Travelling paths (in 
grey/black: before/after application) show drastic changes in trajectories upon peptide 
application. Not only are individuals rotating around a fixed axis in an unusually 
"frozen" shape (see arrows in E), but are also moving in small circular paths within 
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the dish. They periodically underwent massive flattening. Scale bars: 250 m in A 
and E, 200 m in B and F. See also Figure S4 and Tables S1 and S2. 
 
 
Figure 4. FFNPamide, ELPE, MFPF and WPPF provoke flattening and different 
forms of "internal" movement, e.g. churning, in Trichoplax adhaerens. 
Responses of T. adhaerens to a single application of 20 M FFNPamide (A-D), ELPE 
(E-H), MFPF (I-L) or WPPF (M-P). Representative images (A, E, I, M), area (B, F, J, 
N) and speed (D, H, L, P) over time of an example individual. Average numbers of 
flattening events (C, G, K, O) before (0-15' (ctrl)) and after peptide application (15-
30', 30-45')(Mean+StDev). For FFNPamide (C), n=20 animals in 3 trials; for ELPE 
(G), n=42 animals in 5 trials; for MFPF (K), n=39 animals in 5 trials; for WPPF (O), 
n=46 animals in 4 trials. While all 4 peptides invariably yield more frequent 
flattening, each of them induces specific alterations in shape and movements that can 
be observed in the Suppl. video material. Scale bars: 250 m in A, E and I, 170 m in 
M. Statistical tests applied: Wilcoxon for FFNPamide, ELPE, WPPF; Mann-Whitney 
for MFPF; ns, non-significant; *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
See also Figures S2-5 and Tables S1 and S2. 
 
STAR Methods 
 
CONTACT FOR REAGENT AND RESOURCE SHARING  
Further information and requests for resources and reagents should be directed to and 
will be fulfilled by Dirk Fasshauer (dirk.fasshauer@unil.ch). 
EXPERIMENTAL MODEL AND SUBJECT DETAILS  
Animal Maintenance 
Trichoplax adhaerens (Grell strain, haplotype H1) were maintained in large glass 
Petri dishes (15-cm diameter) containing artificial seawater (filtered ASW, salinity of 
1025 ppm (38 g/l) salinity; Coral Pro Salt, Red Sea), at 26°C and under a 12:12 hr 
dark-light cycle. They were fed once a week with 8-10 ml of a 1:1 mixture of 
Nannochloropsis (Florida Aqua Farms) and Pyrenomonas helgolandii (SAG, 
Göttingen, Germany) cultured separately in ASW complemented with 0.03 % of 
Micro Algae Grow (Florida Aqua Farms). About 80 % of the medium was replaced 
every other week. When reaching a population density of over 100-200 individuals 
per dish, 10 to 20 animals were randomly taken up with a pipette to set up a new dish. 
The animals reproduce asexually and their sex was not determined. 
 
 
METHOD DETAILS  
Antibody production 
Polyclonal antibodies were generated in rabbits (2 rabbits per peptide, Speedy 
program, Eurogentec) against peptide candidates [11,12] that were predicted to be 
amidated, namely "FFNPamide" (CQFFNP-amide), "RWamide" (CRDQPPRW-
amide), "SIFGamide" (CQANLKSIFG-amide), "SITFamide" (CNSESTQQGIPSITF-
amide),  "YYamide" (CGYDDYYY-amide), and Insulin-3 "TrIns3" (CPIH-amide). 
For immunization, peptides were coupled to ovalbumin as carrier protein; the cysteine 
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residue added at the N-terminal of the peptides allows for subsequent immobilization 
on a Sulfolink resin (ThermoFisher). Sera were affinity-purified as described [14], 
each resulting in two fractions after elution at pH2.9 and pH2.3. Initial immuno-
stainings were carried out with crude and purified antibodies. The two sera raised 
against each peptide gave similar staining patterns; In all cases, stainings were 
invariably abolished upon pre-incubation of the primary antibody with the peptide it 
was raised against. 
 
Immunolabelling  
T. adhaerens were left to adhere at the bottom of 35-mm plastic Petri dish filled with 
ASW, swiftly replaced by 4 % paraformaldehyde (PFA) with Dextran in ASW for 
fixation (1-2 hrs, RT). After brief washes in ASW followed by 0.1 M phosphate 
buffer pH7.4 (PB) and a 1 hr-blocking step in 3 % normal goat serum (NGS) + 0.2 % 
Triton X-100 in PB, they were incubated for 2 hrs in primary antibody (anti-peptide: 1 
g/ml; anti-FMRFamide (1:300; Enzo Life Sciences #BML-FA1155 or Phoenix 
Pharmaceuticals #H-047-29) in blocking solution. After thorough washes in PB, a 1-
hr incubation in the corresponding secondary antibody coupled to a fluorophore 
(1:600, GAR-Alexa Fluor, Molecular Probes) and further washes in PB, they were 
incubated for 2 minutes in Hoechst (1:10,000; Molecular Probes), rinsed and mounted 
with Prolong-Gold (LifeTech) on glass slides. For co-labelling with antibodies raised 
in the same species, T. adhaerens were instead incubated 45 minutes in a mix of 
antibodies coupled to Alexa fluorophores using the Zenon labelling kit 
(LifeTechnologies) following the manufacturer's instructions, washed in PB, post-
fixed 15 minutes in 4 % PFA, washed again and incubated in Hoechst before being 
mounted on a slide. For blocking experiments, we pre-incubated the antibodies in 
three times excess of the respective peptides for 2 h before immunostainings.  
 
Imaging 
Specimens were imaged on an inverted confocal microscope set-up (Zeiss LSM 780) 
using a 63x-oil immersion objective (NA1.4). Image stacks were acquired over the 
entire thickness of the animal with optical slices of 1.3 m with an overlap of 0.75 
m, with each fluorophore imaged separately. 
 
Behavioural testing 
Most peptides were dissolved in water, except for YYamide and LF, which were 
dissolved in 5 mM NH4HCO3. 10-15 T. adhaerens were pipetted into a 35-mm plastic 
Petri dish filled with 3 ml ASW and allowed to settle for 15-30 minutes at 26°C. The 
dish was then transferred to the stage of a stereomicroscope (Nikon SM225 coupled to 
a Nikon DSR12 camera) with a zoom of 0.63x or 3x, and imaged for 50 minutes. 
After 15 minutes, each peptide (200 nM - 50 M from a 10 mM stock solution) was 
applied once and swiftly mixed in the bath by gentle pipetting. Peptides tested were 
the following: "ELPE" (GKSFELPE), "FFNPamide" (DDQFFNP-amide), Insulin-3 
"TrIns3" (CPIH-amide), "LF" (DDSQDGYALF), "LFNE" (QEPGISLFNE), "MFPF" 
(EDDLPGMFPF), "PWN" (EQGALLDIPWN), "RWamide1" (DQPPRW-amide), 
"RWamide2" (DQPTRW-amide), "RWamide3" (DQPSRW-amide), RWamides 
bearing a N-term pyroGlutamine modification "pGluRWamide1-3", "SIFGamide" 
(EDQANLKSIFG-amide), "SITFamide" (NSESTQQGIPSITF-amide), "WPPF" 
(EDQQNKPYNGWPPF), and "YYamide" (DYDDYYY-amide) (see Table S1 and S2 
for details). Control experiments were carried out by application of the vehicles only. 
Endomorphin-2 (Genscript, RP10926) was tested at concentrations of 1, 15 and 
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50 M. Images were taken every 4 seconds under moderate and constant illumination, 
and at a room temperature of approximately 20°C. Upon recording, the dishes were 
placed back in the incubator with food to check animal viability 24 hrs after 
treatment. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS  
 
Image Analysis and Statistical Methods 
Black and white image series (Tif) were analysed with Fiji. Only individuals that 
were visible during the entire time of the recording were tracked. Since animals in 
close contact may coordinate their behaviours [17,24], only animals which were not 
in contact with one another were monitored to avoid oversampling. In rare cases when 
individuals were in contact with each other, only one was monitored. Images on 
which the application pipettes appeared were not taken into account for analysis. The 
maximum trajectory area was set as ROI for each individual and a time stamp applied 
(see .avi videos as Supplemental information). A threshold (Yen, Fiji) was set to 
optimally define the contour of each individual, allowing for the binarization of the 
image and measurement of the animal's size (area) using the Plugin ‘Analyse 
Particles’ in Fiji. Trajectory, distance covered and speed were assessed from the 
centroid, using the ‘Mtrack2’ Plugin in Fiji. To standardize area variations over 
several animals, the average area was defined for each individual over the first 15 
minutes of recording and used as a baseline to normalize the values over the 
recording. Standard deviations /Standard Errors of the Mean were calculated for each 
time point for all individuals using Excel or Prism. Results are presented as Mean ± 
StDev in Figure 4, Mean ± SEM in Figures S3 and S5. When the values followed a 
normal distribution, a paired t-test was used (Figures S3 and S5). Otherwise, a paired 
Wilcoxon test was applied (Figure 4). 
 
 
 
Video files 
 
Movie S1: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M PWN. 
 
Movie S2: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M SIFGamide. 
 
Movie S3: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M LF. 
 
Movie S4: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M LFNE. 
 
Movie S5: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M FFNPamide. 
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Movie S6: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M ELPE. 
 
Movie S7: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M MFPF. 
 
Movie S8: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M WPPF. 
 
Movie S9: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M SITFamide. 
 
Movie S10: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M YYamide. 
 
Movie S11: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of 20 M pRWamide2. 
 
Movie S12: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of H2O. 
 
Movie S13: Time-stamped videos showing examples of T. adhaerens' behaviour upon 
application of NH4HCO3. 
 
 
 




SUPPLEMENTAL FIGURES 
 
 
Figure S1. Different antibodies against FMRFamide co-label SITFamide-immunoreactive 
cells. Related to Figure 1. 
Anti-FMRFamide antibodies from Enzo (#BML-FA1155; yellow in A) and from Phoenix 
labs (#H-047-29, lot 01479-1; green in B) were used in combination with other peptide 
antibodies. Labelling is illustrated in a single optical slice of the upper epithelium (left 
column) and the lower epithelium (right column) of the same image stack. 
(A) Quadruple staining for FMRFamide from Enzo (FMRF(Enzo), yellow, upper panels), 
SITFamide, FFNPamide and TrIns3 (blue, red and green, lower panels) shows that this 
FMRFamide antibody strongly co-labels SITFamide-immunoreactive cells and to a lesser 
extent, TrIns3-stained cells (arrows). Populations of immunoreactive cells for SITFamide, 
FFNPamide and TrIns3 do not overlap. Of note, the numerous round-shaped white particles 
observed predominantly in the upper epithelium are autofluorescent "concrement vacuoles".  
 (B) Quadruple staining for FMRFamide from Phoenix (FMRF(Phoenix), green, upper 
panels), SITFamide and SIFGamide (red and blue, middle panels) and Hoechst (yellow, lower 
panels) shows that this FMRFamide antibody also strongly co-labels SITFamide-
immunoreactive cells (arrows) but not SIFGamide-stained cells. This antibody also labels a 
row of large cells located close to the edge of the organism (double-arrowheads) and some 
scarce cells of the lower epithelium (circles) likely corresponding to another population of 
unidentified gland cells [8], as well as small unidentified elements in the upper epithelium. 
Populations of immunoreactive cells for SITFamide and SIFG do not overlap. Note again the 
presence of autofluorescent particles, visible in all channels, and the difference of Hoechst-
stained nuclei size and number across both epithelia.  
Scale bar: 30 µm. 
DAPI
SITF SIFG
FMRF(Phoenix)
SITF FFNP TrIns3
FMRF(Enzo)
lower epitheliumupper epithelium
B
A
Varoqueaux et al., Supplemental Figure 1
 
 
 
Figure S2. Average area over time upon application of FFNPamide (n=17), ELPE (n=24), 
MFPF (n=17), WPPF (n=18). Related to Figure 4. 
A single peptide application (arrow) induced a sustained increase of the standard deviation, 
reflecting an effect of the peptide.  
Varoqueaux et al., Supplemental Figure 2
 
Figure S3. Subtle effects of SITFamide, YYamide or pRWamide2 application to Trichoplax 
adhaerens. Related to Figure 4. 
Responses of T. adhaerens to a single application of 20 µM SITFamide (A-D), YYamide (E-
H) or pRWamide2 (I-L). Representative images (A, E, I), area (B, F, J) and speed (D, H, L) 
over time of an example individual. (C, G, K) Average velocities (C, SITFamide, n=15; G, 
YYamide, n=15; pRWamide2, n=15) before (0-15' (ctrl)) and after peptide application (15-
30', 30-45') (Mean+StDev).  Scale bars: 250 µm in A, E and I. Statistical tests applied: 
Wilcoxon for SITFamide, Mann-Whitney for YYamide and pRWamide2; ns, not significant; 
*, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
Varoqueaux et al., Supplemental Figure 3
 
Figure S4. Example traces of behaviours (area and speed) of T. adhaerens individuals upon 
application of the indicated peptides. Related to Figures 2-4. 
 
Varoqueaux et al., Supplemental Figure 4
 
Figure S5. Average speed upon application of endomorphin-2 (n=14) or H2O (n=16). 
Average speed before (0-15' (ctrl)) and after H2O or endomorphin application (15-30', 30-45') 
(Mean+SEM). Statistical test applied: Paired t-test; ns, not significant; *, p<0.05; **, p<0.01; 
***, p<0.001; ****, p<0.0001. Related to Figure 4. 
 
 
 
 
 
 
 
 
 
 
Figure S6. Expression of Trichoplax neuropeptide-precursor-like sequences in single cells.  
scRNAseq data from Sebé-Pedrós et al. [34] were sorted by propeptide normalized expression 
level. 798 cells out of 3,209 single cells expressed at least one of the listed peptides. Data 
were retrieved from GEO Accession: GSE111068. Related to Figure 1. 
 
 
 
  
H20
Endomorphin
Varoqueaux et al., Supplemental Figure 5
  
Table S1. Summary of the peptides tested. Related to Figures 2-4. 
The number of independent trials carried out for a given peptide at a given concentration, as 
well as the number of animals showing or not the described phenotype (see color code) are 
given. Note that the numbers of individuals reported in the main analyses were often lower as 
only animals observable during the entire time of the recording and not touching each other 
were used for quantification. 
*  +/- (x;y/n)   effect or no effect (number of independent trials; number of responsive 
animals/ non-responsive animals) 
** pilot experiments were carried out with RW1amide, RW2amide, RW3amide, 
pRW1amide, pRW2amide and pRW3amide, which showed no drastic effect. 
*** tested at 15 µM 
 
 
 
Table S2. List of T. adhaerens neuropeptide-precursor-like sequences. Related to Figures 1-4. 
Two of the peptides tested identified in this study are highlighted in blue. The epitopes used 
for generating antibodies are highlighted in red in the predicted sequence. 
 
 
Varoqueaux et al., Table S2
Peptide acronym NCBI identifier Predicted sequence Peptide tested
ELPE XP_002116400.1 expressed protein, TRIADDRAFT_64280 MRSIILICLLFLFAAKVNSESFDSDDKRDLFSDEHQRNNDENVVEDGASISRQFASEN
DEDNNEDQIPPLGKSFELPEHRRGKSFEFPEHRRGKSFEFPERRRGKSFELPERRR
GKSFELPERRRGKSFELPERRRGKSFELPERRRGKSFEFPEHRRGKSFEFPLNVLF
QFGNLFRDVLARREGEIKQ
GKSFELPE
FFNPamide XP_002112824.1 expressed hypothetical protein [Trichoplax adhaerens], TRIADDRAFT_63942 MKTLFILLVASVALPLIIAAKDESDSKAETNKRQFNPFFKKEAEVVITNSSVKLDASKAVKVARSEDNLQKKDDQFFNPGKRDDQFFNPDKRDDQFFNPGKRDDQFFNPGKRDD
QFFNPGKRDDQFFNPGKRDDQFFNPGKRDGQFFNPGKRDGQFFNPGKRDGQFFN
PGKRGKKKLYNAFSIIIHLSLNTFIPSLKKYMLYFYNLDGQFFNPGKRDDQFFNPGRR
DDQFFHSRKYDGQFFNPGKREGQFFDKGKRDDQFFNPGKRDGQFFNPGKRDAQF
FNPGRRYDTQFFSPDRRRDTQFFGQRSGKDEQFFGSRGDAQFFGSRRDGQFFNP
GKRDAQFFGSRDDGQFFGSKKDDQFFGHKKEDDQFFGNKKDDAQFFRNNAEETP
SYYSIPRAEFMHENSGTTNNDGNNCTCDGSAPVNPFFM
DDQFFNP-amide
TrIns3 isoform a XP_002111669.1 predicted protein [Trichoplax adhaerens], TRIADDRAFT_55941 MGYCLAILILITVPGLQGDTVRKFCFPDVAQWLIEHCPIHGKSAYNSRYLTKFIVSSLRNLNEECCYTAGCTAANVIKNYC CPIH-amide
LF XP_002108415.1 predicted protein [Trichoplax adhaerens], TRIADDRAFT_51275 MRTILVFTLLVVAVSCRAISKNTDEKSKKPKKTEPKLMIGYPLFKKEDLDSQGYALFRKDDSQGYPLFRKDDSQGYPLFRKDDSQDGYALFRKDDSQPGHALFRKDDSQDGYAL
FRKDAQNGNSILYGHPLFKKEDQDGELSEKADTPLFKKEDSQSADSKKPIIIWKRDG
PSSDSEIPMILFKKRQDDDSEKSEAKNVVSWFSQRDTRKQGFIPFKRGHKRLSYIPN
SNPFKKIFLGDLSSRSEKM
DDSQDGYALF
LFNE XP_002108414.1 predicted protein [Trichoplax adhaerens] TRIADDRAFT_51274 MKICLLVVTIIGLNAIATCKEITDRHVYKNNQEPIINWFKRRQAPPDSGISLFNERQEPGISLFNERQEPGISLFNERQEPGISLFNERQGPGISLFNDRQAPPGASISLSNERQARS
NTGISLFKKRHIFSDADFNNLKRRQDPLISWFEERQESEDPLISWFNERHNPLFSEFN
VRHDPTATSHKEEEEDKNIPGLSLFKREFRSNAKLSKTNYHPQLRLKGSTHFKGILSA
KRNDKLSVSQKRDGYNKKFNTEKLHHSSNILKSKA
QEPGISLFNE
MFPF XP_002113096.1 hypothetical protein TRIADDRAFT_56915 [Trichoplax adhaerens] MSLRLTMFTSCFQIDRHLKIGSVRYLSSKNKYFVIFLFIRIARLIHRLQDLIQKLSYKES
GLHHRPIADSAKDFTASNSNESQDRNEDEKESSLNNQKKSSSQTRSSNHHAREAAD
AMSSHDLHEKKKDDKKLVDDAIQAKKHEEHKRDLSKEHDSRQIRYPFKKEDGQRKW
YPFKKDADQRKWYPFKKDDNQLKWYPFKKDDNLPGTFPFKREDNLPGMFPFKKED
NLPGMFPFKREDDLPGMFPFKRGDNQRKWYPFKKEDNLPGMFPFKRGDNQRKWY
PFKREDDLPGMFPFKRGDDLPGMFPFKRGDSQRKWYPFKREDDLPGMFPFKRGD
NQRKWYPFKREDNLPGMFPFKRGDNQRKWYPFKREDNLPGMFPFKRTTENIN
EDDLPGMFPF
PWN XP_002115879.1 expressed protein [Trichoplax adhaerens], TRIADDRAFT_64214 MAKFLNILIAISLICVLVDCRHIEEQRDVVESLKAKVGFLRDLSDNVARAKKSFHFVENKKRLEAKKSFHFVENKKRLEGVLVDVPWNKRKQGVLVDVPWNKRKQGGLVDIPWN
KREQGALIDIPWNKREQGALLDIPWNKRQQGALLDIPWNKRRQGVLVDVPWNKRQ
EDSHPYIWNKKHDEELDALLKTRRQAKRNERRD
EQGALLDIPWN
RWamide GR951923.1 Trc_1267674.b Trichoplax adhaerens EST Library Trichoplax adhaerens cDNA MLTNRFIIWILFLGITTAQNVAKGKAQIGNHKSVFLKNEATRPERDQPPRWGRDQPTRWGRDQPPRWGRDQPPRWGRDQPSRWGRDQPPRWGRDQPPRWGRDQPPRWG
RDQPPRWGRDQPPRWGRDQPPRWGRDQPPRWGRDQPPRWGRDQPPRWGRD
QPPRWGRDQPPRWGRDQPPRWGGDQLPEMEKNHAPPRWGRDQYSWWNQEQY
PSRWGREYSTPDNTAEKLLDSLTHQSENAKKNNFQEINSDSNSGNESAVHRLFSNK
LKNQKAKSDSNKLMNSFSGSESISRPREKSLKRSETLDNMRIDLI
DQPPRW-amide (RWamide1) 
DQPTRW-amide (RWamide2) 
DQPSRW-amide (RWamide3)
SIFGamide XP_002116174.1 hypothetical protein TRIADDRAFT_60185 [Trichoplax adhaerens] MPRANFIYYIADAFLKEMKQIALIFFLTAAIVFATVNAEGNLESIFNAKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGG
KREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGK
REDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKR
DDQANLKSIFGGKRDDQANLKSIFGGKREDQANLKSIFGGKRDDQANLKSIFGGKRE
DQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGRREDQANLKSIFGGKRED
QANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQ
ANLKSIFGGKREDQANLKSIFGGRREDQANLKSIFGGKREDQANLKSIFGGKREDQA
NLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKREDQAN
LKSIFGGKREDQANLKSIFGGKREDQANLKSIFGGKRKDRANSKKKFGCKCKGRGN
MKSMLGGKREDQANLKSIFDGKREDQANLKSIFGGKREDQANLKSIFGGKRGDQAN
LKSIYGGKREDQANLKSIYGGKREDQANLKSIFGGK
EDQANLKSIFG-amide
SITFamide XP_002117813.1 hypothetical protein TRIADDRAFT_61843 [Trichoplax adhaerens] MATNSIFLSYTILMIAVVVATTPGNARFISSAKRHTLREQPTFIPLGFGRRNLEDIKVSRQSHNSDVLDRRNSESIQQGMPSIMFGKRNSESTQQGIPSITFGKRNSESTQQGIPSI
TFGKRNSASTQQGIPSITFGKRNSESIQQGIPSITFGKRNGKSIQQGIPSITFGKRNSE
SIRQNIPPIMFGKRDSKRMEFRMPTLTFSNRDNEPKLYGLPSINLHKRDAWTKQTIVP
RDNLLARQLYNYGPEMYTMPEDIAYLTSMTEPSSLDYQLSFAQSTPDSKAFGKYNLP
IWNLDSTGLASGGFVDVPTVYLESGNEIPMAMLKRRSSERFTKDMSTSYDQKKKLF
LGLPRFGDQDRSAKSALKDELRLINRKREYKQPPPIIYEGK
NSESTQQGIPSITF-amide
WPPF XP_002112391.1 hypothetical protein TRIADDRAFT_56359 [Trichoplax adhaerens] MYRLSLCCIIILVLFANEIEPKFAKPKEDIPWNLQRRSNANNLKSRSDSAKLSNTEHKKKDLVAEEQSHPIFGKGLVNEAKKTSRNEALQYNGWPPFRREDESKQYNGWPPFRR
EDESKQYNGWPPFRRSDELTQYNGWPPFRRNDGKEQYNGWPPFRRNAGMMQYN
GWPPFRRDDEKMQYNGWPPFRREDREKQYNGWPPFRRDDEVMQYNGWPPFRR
SEAVQYNGWPPFRRDDQQNKPYNGWPPFRREDQQNKPYNGWPPFRRDDQQNKP
YNGWPPFRRNDQQKKPYNGWPPFRRNN
EDQQNKPYNGWPPF
YYamide XP_002112450.1 predicted protein [Trichoplax adhaerens], TRIADDRAFT_56480 MKIAFIFLIVLALSYHIFGNPIKDHDSYSGGYGNDRHKSKTKGIVYKEVRKYVKNDHARPYYNVGYKGKKGYDDYYYIGKKDYDDYYYGKKGYDDYYYGKKMYNDYDKKGGYS
NNYYGRKGHDDYYGGKKDYNDYGKKDYGQEGYYYGYYKQGQDSHGKGKSGRNY
GYQDIYGDKKHDYDYYTEY
DYDDYYY-amide
Endomorphin-like AQX36197.1 endomorphin-like preproprotein [Trichoplax adhaerens] MDHKIKILALIVIAVAGLSSGKSMDKNGRNSVSLWTSAARDSKLAERNDQRKGYIYWETKRDENPESLALFKRKDNLLEDYPFFGNKKRQDYPFFGNKKRQDYPFFGSRKRQ
NLREDKVDSSDDMWDFLERDIIPFWKRNRLASIKRSRMN
YPFF-amide Genscript 
RP10926
